Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Implantable Pulse Generator Market Size from 2025 to 2034?

The market size for implantable pulse generators has seen robust growth in the past few years. The market is projected to expand from $133.75 billion in 2024 to $147.01 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The significant growth during the historical period is attributed to the surge in home healthcare facilities, more widespread use of neuromodulation for disease management, an increased rate of patient diagnosis, the growing utilization of medical devices, and heightened patient awareness.

Predicted rapid expansion is on the horizon for the implantable pulse generator market, with projections suggesting a growth to $221.62 billion by 2029. This represents a compound annual growth rate (CAGR) of 10.8%. Several factors are expected to drive this growth within the forecasted period, including an increase in healthcare spending, patients favoring less invasive procedures, advantageous reimbursement policies, wider application areas, and the growing usage of these implants in different therapies. Key trends for this forecasted period include the downsizing of devices, improvement in battery longevity, wireless connectivity development, smart implantable gadgets and the incorporation of artificial intelligence and machine learning.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Implantable Pulse Generator Market?

The increasing prevalence of neurological disorders is projected to fuel the expansion of the implantable pulse generator market. Neurological disorders encompass conditions that impact the brain, spinal cord, and nervous system, affecting aspects like motion, sensation, and cognition. The rise in neurological disorders is often linked to factors such as aging demographics, lifestyle shifts, environmental factors, and enhanced diagnostic methods. Implantable pulse generators assist in handling neurological disorders by delivering specific electrical impulses to regulate abnormal neural activity and relieve symptoms. For instance, the Parkinson Foundation, a non-profit organisation based in the US, reported in December 2022 that by 2020, 930,000 individuals in the U.S had Parkinson’s disease (PD), with forecasts suggesting this figure will increase to 1.2 million by 2030. Hence, the increasing prevalence of neurological disorders is a significant factor contributing to the expansion of the implantable pulse generator market.

Which Key Market Segments Comprise the Implantable Pulse Generator Market and Drive Its Revenue Growth?

The implantable pulse generatormarket covered in this report is segmented –

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices

2) By Charging Type: Rechargeable, Non Rechargeable

3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Subsegments:

1) By Implantable Cardiac Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers

2) By Implantable Defibrillators: Implantable Cardioverter Defibrillators (ICD), Subcutaneous Implantable Defibrillators (S-ICD)

3) By Cochlear Implants: Single-Channel Cochlear Implants, Multi-Channel Cochlear Implants

4) By Implantable Nerve Stimulators (Fes): Functional Electrical Stimulation (FES) Devices For Motor Function Restoration, Spinal Cord Stimulation Devices

5) By Implantable Infusion Pumps: Insulin Pumps, Pain Management Pumps, Intrathecal Drug Delivery Pumps

6) By Implantable Active Monitoring Devices: Continuous Glucose Monitoring Systems, Cardiac Monitoring Devices, Neurological Monitoring Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18639&type=smp

Which Areas Are Leading Regions in the Implantable Pulse Generator Market Expansion Across the Globe?

North America was the largest region in the implantable pulse generator market in 2024. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theImplantable Pulse Generator Market Over the Coming Years?

Large corporations in the implantable pulse generator market are shifting their attention to the creation of innovative neuromodulation devices, with the goal of improving the quality and results of treatments, as well as making these devices applicable to a wider variety of neurological conditions. A neuromodulation device is a specifically designed medical device that changes nerve activity by delivering electrical impulses or pharmaceutical agents to designated areas of the nervous system. For example, CVRx Inc., a medical device firm based in the United States, introduced the new Barostim NEO2 IPG, an implantable pulse generator designed for patients undergoing therapy, in November 2022. The Barostim system uses neuromodulation to alleviate symptoms of heart failure by sending electrical impulses to the baroreceptors in the wall of the carotid artery. This stimulation activates the body’s baroreflex, which in turn triggers a response in the heart from the autonomic system. The goal of this therapy is to bring equilibrium to the autonomic nervous system and relieve symptoms of heart failure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

How Is the Implantable Pulse Generator Market Conceptually Defined?

An implantable pulse generator (IPG) refers to a medical device used to deliver electrical impulses to specific nerves or muscles within the body. It is commonly used in neuromodulation therapies to manage conditions such as chronic pain or movement disorders. The IPG is surgically implanted under the skin and can be programmed to adjust stimulation levels as needed.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18639

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model